Report: Immune Checkpoint Proteins Are the Focus of Cancer Immunotherapy Development – AJMC.com Managed Markets Network
|
Report: Immune Checkpoint Proteins Are the Focus of Cancer Immunotherapy Development
AJMC.com Managed Markets Network Advancements in the cancer immunotherapy pipeline are leading to the production of immune checkpoint inhibitors, and a recent report from Global Business Intelligence (GBI) Research titled “Cancer Immunotherapies—First-in-Class Pipeline Dominated by … |
